Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Exisulind/docetaxel combination prolongs survival in animal model of lung cancer

Sep. 25, 2000

New series of MMP inhibitors for inhibiting tumor growth and metastasis

Sep. 25, 2000

Binding properties of potent antileukemic drug STI-571 revealed

Sep. 25, 2000

NO-releasing agents for chemoprevention of colon cancer focus of NCI grant

Sep. 25, 2000

Zycos licenses gene-based oncology product

Sep. 25, 2000

Two recently issued patents cover Pfizer's new PTK inhibitors

Sep. 22, 2000

Roche and BMS form alliance to study Herceptin/Taxol anticancer combination

Sep. 22, 2000

IntraDose receives orphan drug status for melanoma indication

Sep. 22, 2000

Genta presents clinical trial update for Genasense

Sep. 22, 2000

Thalidomide improves tolerability of irinotecan in colorectal cancer patients

Sep. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...